Overview

FolateScan in Autoimmune Disease

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will gather information on the safety of FolateScan and the ability of FolateScan to detect inflammation in the joints and other organs in people with arthritis (rheumatoid arthritis and osteoarthritis), systemic lupus erythematosus, multiple sclerosis, interstitial pneumonitis, Crohn's disease as well as in healthy persons without these conditions.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Endocyte